Restoration of normal phenotype in cancer cells
Patent
·
OSTI ID:321195
A method for reversing expression of malignant phenotype in cancer cells is described. The method comprises applying {beta}{sub 1} integrin function-blocking antibody to the cells. The method can be used to assess the progress of cancer therapy. Human breast epithelial cells were shown to be particularly responsive. 14 figs.
- Research Organization:
- University of California
- Sponsoring Organization:
- USDOE, Washington, DC (United States)
- DOE Contract Number:
- AC03-76SF00098
- Assignee:
- Univ. of California, Oakland, CA (United States)
- Patent Number(s):
- US 5,846,536/A/
- Application Number:
- PAN: 8-726,230
- OSTI ID:
- 321195
- Country of Publication:
- United States
- Language:
- English
Similar Records
Restoration of normal phenotype in cancer cells
Method for restoration of normal phenotype in cancer cells
Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin ?5?1 and Fibronectin
Patent
·
1997
·
OSTI ID:872022
Method for restoration of normal phenotype in cancer cells
Patent
·
1999
·
OSTI ID:873261
Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin ?5?1 and Fibronectin
Journal Article
·
2010
· Cancer Research
·
OSTI ID:1004598